Latest Articles
New research challenges menstrual taboo to promote more inclusive workplaces - Phys.org
New research challenges menstrual taboo to promote more inclusive workplaces Phys.org
Published: Nov. 30, 2025, 7:40 p.m.
Researchers issue warning after discovering overlooked threat to reproductive health: 'More significant effects' - Yahoo
Researchers issue warning after discovering overlooked threat to reproductive health: 'More significant effects' Yahoo
Published: Nov. 27, 2025, 11 p.m.
Research Challenges Menstrual Taboo, Promotes Inclusion - Mirage News
Research Challenges Menstrual Taboo, Promotes Inclusion Mirage News
Published: Nov. 27, 2025, 12:18 p.m.
Endometriosis Treatment Market Size, Share & Growth Report by 2034 - Straits Research
Endometriosis Treatment Market Size, Share & Growth Report by 2034 Straits Research
Published: Nov. 26, 2025, 11:31 a.m.
Molecular mechanısms of ovarian fibrosis.
Ovarian fibrosis is increasingly recognized as a pivotal factor contributing to ovarian aging, dysfunction and female infertility. It results from chronic or repetitive ovarian injury, such as that caused by …
Published: Nov. 26, 2025, midnight
Synergyne Imaging Technology Inc. Publishes Breakthrough Research on AI-Based Endometrial Ultrasound Analysis - EIN News
Synergyne Imaging Technology Inc. Publishes Breakthrough Research on AI-Based Endometrial Ultrasound Analysis EIN News
Published: Nov. 25, 2025, 5 p.m.
RCOG Publishes Top 10 Women’s Health Research Priorities - Femtech Insider
RCOG Publishes Top 10 Women’s Health Research Priorities Femtech Insider
Published: Nov. 25, 2025, 11:15 a.m.
Why is Endometriosis still under-researched? - Times of India
Why is Endometriosis still under-researched? Times of India
Published: Nov. 25, 2025, 10:34 a.m.
Why is Endometriosis still under-researched? - The Times of India
Why is Endometriosis still under-researched? The Times of India
Published: Nov. 25, 2025, 10:34 a.m.
Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium.
Mesonephric-like adenocarcinoma (MLA) is a rare and aggressive gynecologic malignancy that has only been recognized in the last decade. It arises in the endometrium, ovaries, and other extrauterine sites (often …
Published: Nov. 24, 2025, midnight
Link copied to clipboard!